Retinoic acid reduces the cytotoxicity of cyclopentenyl cytosine in neuroblastoma cells

FEBS Lett. 2002 Sep 11;527(1-3):229-33. doi: 10.1016/s0014-5793(02)03234-9.

Abstract

In this paper, it is demonstrated that all-trans, 9-cis and 13-cis retinoic acid (RA) decreased the sensitivity of SK-N-BE(2)c neuroblastoma cells towards the chemotherapeutic agent cyclopentenyl cytosine (CPEC), a potent inhibitor of cytosine-5'-triphosphate synthetase. Retinoic acid attenuated CPEC-induced apoptosis as reflected by a decreased caspase-3 induction. Retinoic acid decreased the accumulation of CPEC, whereas the salvage of cytidine was strongly increased. Metabolic labeling studies using [(3)H]uridine showed a strongly decreased biosynthesis of CTP via CTP synthetase. Retinoic acid likely confers resistance of neuroblastoma cells to CPEC in part by slowing down proliferation, and in part by shifting the synthesis of CTP towards the salvage of cytidine, thereby bypassing CTP synthetase.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Apoptosis / drug effects
  • Cell Differentiation / drug effects
  • Cell Division / drug effects
  • Cytidine / analogs & derivatives*
  • Cytidine / pharmacology*
  • Cytidine Triphosphate / biosynthesis
  • Drug Interactions
  • Humans
  • Neuroblastoma / drug therapy*
  • Neuroblastoma / metabolism
  • Neuroblastoma / pathology
  • Polyphosphates / metabolism
  • Tretinoin / pharmacology*
  • Tumor Cells, Cultured

Substances

  • Antineoplastic Agents
  • Polyphosphates
  • Tretinoin
  • Cytidine
  • Cytidine Triphosphate
  • cyclopentenyl cytosine
  • triphosphoric acid